NVDA
NVIDIA Corporation
NVDA has the edge over PRTH overall, supported by stronger modeled upside and stronger valuation.
PRTH
Priority Technology Holdings, Inc.
PRTH trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PRTH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Weak |
PRTH's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over PRTH in the historical PE scenario, which offers more potential upside but is not a forecast.
PRTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.8x | $7.91 | — |
| Cheap | 8.3x | $3.98 | -50% |
| Fair | 16x | $7.84 | -0.9% |
| Current | 16x | $7.91 | — |
| Expensive | 28x | $13.51 | +71% |
Historical ranges are pointers, not guarantees.
PRTH's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 6.8x next year's earnings, in its cheap range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PRTH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PRTH, but weaker profitability.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
PRTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.17 | +144% |
| Q2 2021 | $0.20 | +$0.61 |
| Q1 2021 | $0.43 | +$0.93 |
| Q4 2020 | $0.38 | +$0.89 |
PRTH has the edge over NVDA in the latest year-over-year earnings comparison.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PRTH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PRTH on profitability, with a higher operating margin.
PRTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $268.6M | +11% |
| Q2 2026 | $262.3M | +9.4% |
| Q1 2026 | $249.6M | +11% |
| Q4 2025 | $247.1M | +8.8% |
| Q3 2025 | $241.4M | +6.3% |
| Q2 2025 | $239.8M | +9.1% |
| Q1 2025 | $224.6M | +9.2% |
| Q4 2024 | $227.1M | +14% |
PRTH's revenue has grown year over year every quarter since late 2020: $269M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | -2.3 points |
| Q2 2026 | 13% | -3 points |
| Q1 2026 | 13% | -1.1 points |
| Q4 2025 | 14% | -1.5 points |
| Q3 2025 | 16% | -1.1 points |
| Q2 2025 | 16% | +0.5 points |
| Q1 2025 | 15% | +0.9 points |
| Q4 2024 | 15% | +4 points |
PRTH's operating margin was 13% last quarter, down 2.3 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
PRTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $34.9M | +16% |
| Q2 2026 | $24.4M | +165% |
| Q1 2026 | $18.3M | +277% |
| Q4 2025 | $30.9M | +62% |
| Q3 2025 | $30.1M | +107% |
| Q2 2025 | $9.2M | -61% |
| Q1 2025 | $4.9M | -27% |
| Q4 2024 | $19.1M | +638% |
PRTH generated $108M in free cash flow over the past year, up 71% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over PRTH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
PRTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +470K shares |
| 1 year | +3.9% | +3.2M shares |
| 3 years | +7.5% | +5.9M shares |
| 5 years | +25% | +16.8M shares |
| Available history | +26% | +17.2M shares |
PRTH has 84M diluted shares, up 3.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | $777,000 |
| Q4 2022 | $2.8M |
| Q3 2022 | $2.6M |
| Q4 2021 | $680,000 |
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over PRTH on leverage, with a lower net debt burden relative to earnings.
PRTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.3x | High |
| Q2 2026 | 4.4x | High |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 4.7x | High |
| Q3 2025 | 4.8x | High |
| Q2 2025 | 4.4x | High |
| Q1 2025 | 4.5x | High |
| Q4 2024 | 4.6x | High |
PRTH's net debt is about 4.3 years of its operating earnings (EBITDA), down from 4.8 years a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PRTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.4 | Neutral |
| Stochastic | 98.7 | Overbought |
PRTH's weekly RSI is 66 (neutral) and its Stochastic is 99 (overbought).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PRTH PE vs Technology Sector
| Metric | PRTH | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 28x | 41% below |
| PE % | 51 | 35 | 16 pts above |
PRTH has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
PRTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.83 | 1% above |
| 20 week MA | $6.78 | 17% above |
| 50 week MA | $6.09 | 30% above |
| 100 week MA | $7.02 | 13% above |
| 200 week MA | $5.67 | 40% above |
PRTH has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
PRTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.60 | $6.36 | +145% |
| 2021 | $6.36 | $7.21 | +13% |
| 2022 | $7.21 | $5.32 | -26% |
| 2023 | $5.32 | $3.56 | -33% |
| 2024 | $3.56 | $11.0 | +210% |
| 2025 | $11.0 | $5.53 | -50% |
| 2026 YTD | $5.53 | $7.91 | +43% |
PRTH has the edge over NVDA on returns for 2026, with the stronger performance.